Brian D. Lo, MD
San Diego—Patient blood management (PBM) programs have focused largely on reducing red blood cell usage, but new research highlights the importance of also considering platelets and fresh frozen plasma.
Investigators at the Johns Hopkins University School of Medicine, which is a leader in this area of research, concluded that focusing on these “yellow” components as part of PBM can significantly improve blood product utilization and costs.
“Over the past